Found 1 results
Filters: Keyword is Phosphatidylinositol 3-Kinase [Clear All Filters]
A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes. Breast Cancer Res. 2014;16(6):482. doi:10.1186/s13058-014-0482-y
